文献速递妇科产科

高血糖促进不依赖胰岛素的卵巢肿瘤生长

Hyperglycemia promotes insulin-independent ovarian tumor growth.
PubMed 文献 · Gynecol Oncol · 2018-02-17

上皮性卵巢癌(EOC)早期诊断困难且致死率高,合并糖尿病与预后不良相关,既往认为胰岛素信号是驱动因素。本研究在小鼠原位卵巢肿瘤模型中诱导急性1型(低胰岛素)或2型(高胰岛素)糖尿病,发现高血糖以葡萄糖浓度依赖方式加速肿瘤生长并显著缩短总生存期,而肿瘤存在可改善两型糖尿病的糖耐量受损;慢性1型糖尿病中高血糖限制肿瘤生长但不改变总生存期;体外长期培养于25mM vs 6mM葡萄糖下生长与代谢显著不同。结论提示全身代谢紊乱对卵巢肿瘤生长和总生存期有深远影响。

要点

  • 高血糖以葡萄糖浓度依赖方式加速小鼠原位卵巢肿瘤生长并显著缩短总生存期。
  • 肿瘤存在可改善1型和2型糖尿病小鼠的糖耐量受损。
  • 慢性1型糖尿病中高血糖限制肿瘤生长但不改变总生存期。

核心结论

  • 全身代谢紊乱可对卵巢肿瘤生长和总生存期产生深远影响。

研究设计与样本

  • 在小鼠中诱导原位卵巢肿瘤,并设置急性1型(低胰岛素)或2型(高胰岛素)糖尿病模型。
  • 体外将细胞长期培养于25mM vs 6mM葡萄糖以比较生长与代谢。

主要发现

  • 高血糖以葡萄糖浓度依赖方式加速卵巢肿瘤生长并显著缩短总生存期。
  • 肿瘤存在可改善1型和2型糖尿病小鼠的糖耐量受损。
  • 慢性1型糖尿病小鼠中高血糖限制肿瘤生长但不改变总生存期,提示全身代谢应激可独立于原发肿瘤大小加速死亡时间。
  • 体外25mM vs 6mM葡萄糖长期培养下生长与代谢显著不同。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Epithelial ovarian cancer (EOC) is notoriously difficult to diagnose in its earlier and more treatable stages, making it one of the deadliest cancers in women. Comorbid diabetes is associated with poor prognosis in EOC and pro-growth insulin signalling is often considered to be the driving factor. However, EOC cells are also highly glycolytic and insulin-independent glucose uptake is essential to their metabolism. Evidence of gluconeogenesis in cancer in vivo suggests that the normal concentration of circulating glucose does not meet the energy demands of the tumor and may therefore be a limiting factor in cancer cell metabolism. Diabetics have elevated blood glucose that has the potential to meet these energy demands and facilitate cancer progression. METHODS: To determine whether hyperglycemia is a potentially modifiable factor independent of insulin, orthotopic ovarian tumors were induced in mice with acute Type 1 (hypo-insulinemic) or Type 2 (hyper-insulinemic) diabetes. RESULTS: Hyperglycemia accelerated the growth of ovarian tumors in a glucose concentration-dependent manner and significantly shortened overall survival. Reciprocally, the presence of a tumor improved impaired glucose tolerance in both Type 1 and Type 2 diabetes. In mice with chronic Type 1 diabetes, hyperglycemia limited tumor growth without changing overall survival, indicating that systemic metabolic stress can accelerate time to death independent of primary tumor size. When modeled in vitro, long-term culture in 25mM vs 6mM glucose resulted in significantly different growth and metabolism. CONCLUSIONS: Taken together, this study shows that systemic metabolic disturbances can have a profound impact on both the growth of ovarian tumors and on overall survival.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Kellenberger LD, Petrik J. Hyperglycemia promotes insulin-independent ovarian tumor growth. Gynecol Oncol. 2018. PMID: 29458977. doi:10.1016/j.ygyno.2018.02.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。